[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![marvin_labs Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1567136554908352514.png) Marvin Labs [@marvin_labs](/creator/twitter/marvin_labs) on x XXX followers
Created: 2025-07-17 10:08:43 UTC

The margin story outpaces the revenue growth at $ELV in 2Q-2025 — but the headline is a guidance cut.

* Operating revenue: $49.4B, up XXXX% year-over-year, exceeding expectations
* Adjusted EPS: $8.84, down XXXX% from a year ago, below expectation of $XXXX
* Adjusted operating margin: 5.0%, down 170bps from XXX% last year
* FY2025 adjusted EPS guidance cut to $XXXXX from previous level (guidance not detailed here)

Lower margin along with a large EPS miss signals significant medical cost headwinds, especially in ACA and Medicaid supports. Revenue growth was strong, seeing impact from premium yield and expansion in Medicare Advantage, but not enough to offset rising costs.

Earnings call scheduled for today at 08:30 am EDT.

![](https://pbs.twimg.com/media/GwDTpGkXEAAiGZO.png)

XXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1945787744338272315/c:line.svg)

**Related Topics**
[eps](/topic/eps)
[$494b](/topic/$494b)
[quarterly earnings](/topic/quarterly-earnings)
[$elv](/topic/$elv)
[stocks healthcare](/topic/stocks-healthcare)

[Post Link](https://x.com/marvin_labs/status/1945787744338272315)